Within the CSA there are five controlled substance schedules at the federal level (Schedules I-V) that are used to classify drugs based upon their:accepted medical applications in the U.S. abuse potential safety and potential for addiction
Second-Order Schedules of Drug Injection One of the most noteworthy features of the behavior of human drug abusers is the extent to which their behavioral repertoire consists of responses maintain... JL Katz,SR Goldberg - Springer New York 被引量: 113发表: 1987年 加载更多来源...
among others. Schedule III drugs along with the other types of scheduled drugs can be found under the category of controlled substances and are placed under these schedules based on their potential for abuse, whether they are likely to cause dependence as a result of abuse or whethe...
Each patient's clinical background, including gastrointestinal and cardiovascular risk factors, should be taken into account when selecting appropriate NSAIDs. New methods are emerging to assist clinicians in the selection of appropriate NSAIDs and their doses/schedules, such as biomarkers th...
Michigan categorizes controlled substances into different “schedules” based on how dangerous or addictive they are. The more dangerous the drug, the harsher the penalties. For example, Schedule I drugs, like heroin, are seen as highly addictive and have no accepted medical use, while Schedule ...
a我们同样有保持 We have the maintenance similarly[translate] abecause patients were treated with drugs with different administration routes and schedules 正在翻译,请等待...[translate]
This booklet—primarily for veterinarians and horse owners, trainers, or any other person in charge or having care of a race horse—contains a schedule of equine drugs, with a focus on drug absorption and elimination times. Information for each drug includes generic, trade, and other names; ...
were used widely as antiarrhythmics in the United States. During the past 15 years there has been a continuous growth in the number of agents available. In this chapter we discuss the electrophysiological bases for the action of antiarrhythmic drugs and review their pharmacological properties. The ...
D’Aquilla RT. HIV-1 drug resistance: molecular pathogenesis and laboratory monitoring. Clin Lab Med 1994; 14: 393–423 Google Scholar Arnold E, Ding J, Hughes SH, et al. Structures of DNA and RNA polymerases and their interactions with nucleic acid substrates. Curr Opin Struct Biol 1995;...
At the same time, the responsibility for adhering to treatment schedules is moved to the patient. Given the often-complex treatment regimens, patients must be well trained and motivated to take their medication correctly. Moreover, patients should have knowledge on the frequency and severity of ...